Jade Biosciences, Inc. (JBIO) delivered a return of 128.73% over the past year. Since JBIO does not currently pay dividends, the total return equals the price-only return.

A $10,000 investment in Jade Biosciences, Inc. one year ago would be worth $22,873 today, representing a gain of $12,873.

Jade Biosciences, Inc. (JBIO) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For JBIO, the total return equals the price-only return.

Yes, Jade Biosciences, Inc. (JBIO) outperformed the S&P 500 by 106.05 percentage points over the past year. JBIO delivered a total return of 128.73%, compared to the S&P 500's 22.68%. This 106.05pp alpha means investors in JBIO earned more than a passive S&P 500 index fund.

Jade Biosciences, Inc. (JBIO) experienced a maximum drawdown of -39.23% over the past year, declining from its peak on 2026-04-27 to its trough on 2026-06-08. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Here are Jade Biosciences, Inc. (JBIO)'s long-term returns with dividends reinvested. Over 10 years, the total return is -97.7% (-31.4% CAGR) — $10,000 would have grown to $231. Over 20 years: -97.7% total return (-17.2% CAGR) — $10,000 → $231. Over 30 years: -97.7% total return (-11.8% CAGR) — $10,000 → $231. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Jade Biosciences, Inc.'s best calendar year was 2022 with a total return of 168.1%. Its worst year was 2024 with a total return of -87.8%. This range shows the volatility investors should expect — the difference between the best and worst year is 255.9 percentage points.